There was a mistake in Figure 6A as published. The resolution of the immunofluorescence image was insufficient and did not meet the required quality for clear presentation. The corrected Figure 6 appears below.
FIGURE 6.
EDA Inhibited NLRP3 inflammasome activation in vitro. BV-2 cells were treated with EDA for 1 h followed by the application of LPS (100 ng/mL) for 24 h. (A) Immunofluorescence detection of NLRP3 inflammasome in BV-2 cells were performed. Scale bar = 10 μm. (B) The protein expressions of NLRP3, ASC and caspase-1 were detected by Western blot assay. The ratio of densitometry values of NLRP3, ASC and caspase-1 with β-actin were assessed and normalized to each respective control cultures. Data were the mean ± SEM from six independent experiments performed in triplicate. ***p < 0.001 compared with control cultures; #p < 0.05, #p < 0.01 compared with LPS-treated cultures.
The original article has been updated.
Footnotes
Edited and reviewed by: Matilde Otero-Losada, National Scientific and Technical Research Council (CONICET), Argentina
Generative AI statement
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.